Trending archive

Every article that has appeared in Trending stays here. Search by title, journal, author or PMID, and narrow by date.

2000 articles

September 202624

Case ReportHematology

Extramedullary T-Lymphoblastic Blast Crisis in Chronic Myeloid Leukaemia: A Unique Cytologic Diagnosis Confirmed by Flow Cytometry.

A 40-year-old man presented with generalized lymphadenopathy, hepatosplenomegaly, anemia, and marked leukocytosis. Bone marrow examination indicated chronic phase chronic myeloid leukaemia (CML) with confirmed BCR::ABL1…

CytopathologySep 7, 2026Read case
Case ReportOncology (Medical)

Primary Cerebral Pleomorphic-Myxoid Sarcoma With Many Hyaline Globules.

A 59-year-old man presented with a primary sarcoma in the right temporal lobe, following a history of pituitary tumor resection and radiotherapy 40 years prior.

NeuropathologySep 7, 2026Read case
Case ReportHematologyOpen access

Testicular aggressive B-cell lymphoma with plasmablastic morphology harboring concurrent IGH::MYC and IGH::BCL2 rearrangements.

A 66-year-old immunocompetent man presented with a 5 cm left testicular mass. Histological analysis showed a diffuse proliferation of large atypical lymphoid cells with plasmablastic morphology.

J HematopSep 7, 2026Read case
Clinical ResearchOncology (Medical)

The role of particle therapy in the treatment of locally recurrent rectal cancer: a systematic review.

This systematic review evaluated the role of particle therapy in treating locally recurrent rectal cancer, particularly in patients with unresectable or inoperable cases.

Radiol OncolSep 7, 2026Read summary
Clinical ResearchOncology (Medical)

Transcriptomic analysis of a phase 1 trial for intraperitoneal monocytes plus IFNs in ovarian cancer reveals support and recruitment of cell-mediated immunity.

This phase 1 trial investigated the effects of intraperitoneal autologous monocytes with interferons (AMIGA) in women with recurrent, platinum-resistant ovarian cancer.

J Immunother CancerSep 7, 2026Read summary
Clinical ResearchOncology (Medical)

Chemotherapy with or without pembrolizumab followed by maintenance pembrolizumab with or without olaparib as first-line treatment of patients with advanced BRCA non-mutated epithelial ovarian cancer (ENGOT-OV43/GOG-3036/KEYLYNK-001): a randomised, double-blind, placebo-controlled, phase 3 trial.

This phase 3 randomized trial evaluated the efficacy and safety of pembrolizumab plus chemotherapy followed by pembrolizumab plus olaparib maintenance in 1367 women with advanced BRCA non-mutated epithelial ovarian…

Lancet OncolSep 7, 2026Read summary
Clinical ResearchOncology (Medical)Open access

Evidence Gap in Managing Lateral Pelvic Lymph Nodes in Rectal Cancer: a Systematic Review of Radiation Boost Strategies.

This systematic review assessed radiation dose escalation to radiologically suspicious lateral pelvic lymph nodes (LPLNs) during neoadjuvant chemoradiotherapy for locally advanced rectal cancer.

J Gastrointest CancerSep 7, 2026Read summary
Case ReportOncology (Medical)

Intravascular large B-cell lymphoma with reversible central hypopituitarism.

A woman in her late 60s presented with fever and general fatigue. Investigations showed bicytopenia, splenomegaly, and central hypothyroidism.

BMJ Case RepSep 7, 2026Read case
Clinical ResearchOncology (Medical)Open access

How prevalent is fear of cancer recurrence beyond 5 years: a systematic review of validated assessments across tumour types.

This systematic review examined the prevalence of fear of cancer recurrence (FCR) in survivors beyond 5 years across various tumor types.

Support Care CancerSep 7, 2026Read summary
Case ReportOncology (Medical)

Management of oral stomatitis associated with BRAFi-MEKi therapy using intralesional corticosteroid and local anesthetic: a case report.

A 66-year-old woman with a history of choroidal melanoma developed a fibrinopurulent ulcer on the tongue after starting dabrafenib-trametinib therapy for tumor recurrence.

Einstein (Sao Paulo)Sep 7, 2026Read case
Clinical ResearchRheumatology

Profiling immune check point inhibitors - Induced arthritis: A systematic review and pooled analyses of cohort studies.

This systematic review and pooled analysis of cohort studies characterized immune checkpoint inhibitor–induced arthritis (ICIs-IA) in patients treated for cancer.

J AutoimmunSep 6, 2026Read summary
Case ReportObstetrics & Gynecology

Laparoscopic Resection of Vaginal Cuff Recurrence Following Surgery for Endometrial Cancer.

Vaginal cuff recurrence of endometrial cancer is generally managed with radiotherapy, and surgical reports are scarce. We report a laparoscopic resection technique for isolated vaginal cuff recurrence.

Tokai J Exp Clin MedSep 6, 2026Read case
Case ReportHematology

Successful Engraftment Following Second Cord Blood Transplantation After Graft Failure in a Child With Relapsed B-ALL.

A 9-year-old boy with relapsed B-cell precursor acute lymphoblastic leukemia experienced primary graft failure after his first umbilical cord blood transplantation due to low CD34-positive cell dose and significant HLA…

Tokai J Exp Clin MedSep 6, 2026Read case
Case ReportHematology

Adult-Onset Langerhans Cell Histiocytosis With Calvarial and Hypothalamic Involvement: Two Cases.

This report details two cases of adult-onset Langerhans cell histiocytosis (LCH). The first case involved a 36-year-old woman with a solitary osteolytic lesion in the calvarium, treated with surgical resection and…

Tokai J Exp Clin MedSep 6, 2026Read case
Clinical ResearchHematologyOpen access

CAR T-cell therapy as a definitive consolidation for older adults with B-ALL in first complete remission.

This phase 1 clinical trial evaluated the safety and efficacy of CD19 CAR T-cell therapy as consolidation treatment in older adults (≥55 years) with B-cell acute lymphoblastic leukemia (B-ALL) in first complete…

Blood AdvSep 6, 2026Read summary
Clinical ResearchHematologyOpen access

Long-term outcomes of azacitidine, venetoclax, and gilteritinib in newly diagnosed FLT3-mutated AML.

This phase II clinical trial evaluated the long-term outcomes of azacitidine, venetoclax, and gilteritinib in 30 adults with newly diagnosed FLT3-mutated acute myeloid leukemia (AML) unfit for intensive chemotherapy.

Blood AdvSep 6, 2026Read summary
Clinical ResearchOncology (Medical)

Induction and consolidation atezolizumab with stereotactic body radiation therapy versus radiation alone in high-risk, early-stage non-small-cell lung cancer (SWOG/NRG S1914): a multicentre, open-label, superiority, phase 3, randomised controlled trial.

This phase 3, multicentre, randomised controlled trial evaluated the addition of atezolizumab to stereotactic body radiation therapy (SBRT) in patients with high-risk, early-stage non-small-cell lung cancer (NSCLC).

LancetSep 6, 2026Read summary
Clinical ResearchOncology (Medical)Open access

Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphoma.

This multicenter, single-arm, phase 1/2 trial assessed the safety and efficacy of CD19-directed CAR-T therapy CTX110 in 63 adults with relapsed/refractory B-cell non-Hodgkin lymphoma.

Blood AdvSep 6, 2026Read summary
Case ReportDermatologyOpen access

Primary cutaneous epithelioid hemangioendothelioma of the temporal region: a case report.

A 70-year-old female presented with a progressively ulcerated plaque on her left temple. Histopathological analysis confirmed primary cutaneous epithelioid hemangioendothelioma (EHE) through characteristic features and…

Pan Afr Med JSep 6, 2026Read case
Clinical ResearchHematologyOpen access

Baricitinib for refractory chronic graft-versus-host disease: results of a phase 1/2 study.

This phase 1/2 study evaluated the safety and efficacy of baricitinib, a JAK 1/2 inhibitor, in 24 adults with refractory chronic graft-versus-host disease (cGVHD) after hematopoietic cell transplantation.

Blood AdvSep 6, 2026Read summary
Case ReportUrology

Extraperitoneal Single-Port Robotic-Assisted Radical Cystectomy with Orthotopic Ne-obladder: Technique and Surgical Considerations.

Radical cystectomy (RC) is the standard therapy for muscle-invasive bladder cancer (MIBC) and refractory high-risk non-muscle-invasive bladder cancer (1-3).

Int Braz J UrolSep 6, 2026Read case
Case ReportOncology (Medical)Open access

Locoregional recurrence of triple-negative breast cancer with low tumor-infiltrating lymphocytes: a case report.

A 49-year-old postmenopausal woman with triple-negative breast cancer (TNBC) experienced an unusual locoregional recurrence three months after a Patey mastectomy.

Pan Afr Med JSep 6, 2026Read case
Clinical ResearchHematology

Safe Accelerated Venetoclax Escalation: a phase 1b study of obinutuzumab plus venetoclax with daily ramp-up in CLL.

This phase 1b clinical trial evaluated the safety and efficacy of an accelerated 5-day inpatient venetoclax ramp-up in 40 patients with chronic lymphocytic leukemia (CLL).

Blood AdvSep 6, 2026Read summary
Clinical ResearchOncology (Medical)Open access

Instruments for measuring body image in breast cancer patients: a systematic review of measurement properties.

This systematic review evaluated the psychometric properties of patient-reported outcome measures (PROMs) for body image in breast cancer patients. Thirty-eight articles assessing fifteen PROMs were included.

Qual Life ResSep 6, 2026Read summary

Showing the most recent matches. Add a word or a date to reach older ones.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.